US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Notice of Extraordinary General Meeting of Terveystalo Plc

Notice of Extraordinary General Meeting of Terveystalo Plc Notice is given to the shareholders of Terveystalo Plc (the "Company") to an Extraordinary General Meeting to be held on 30 June 2026 at 2:30 p.m. (EEST) without a meeting venue as a real-time virtual meeting in accordance with Article 7 of the Articles of Association of the Company and Chapter 5, Section 16, Subsection 3 of the Finnish Companies Act. Instructions for participation are presented in this notice under section C "Instructions for the participants in the Extraordinary General Meeting". A. Matters on the agenda of

Inside information: Terveystalo to acquire Silmäasema to accelerate growth and increase presence in the growing eye care market

Terveystalo Plc INSIDE INFORMATION 8 June 2026 at 08:05 EEST Inside information: Terveystalo to acquire Silmäasema to accelerate growth and increase presence in the growing eye care market Terveystalo Plc ("Terveystalo") and its subsidiary, Terveystalo Healthcare Oy, have today signed a share purchase agreement to acquire all shares in Silmäasema Oy ("Silmäasema") (the "Transaction") with Coronaria Oy ("Coronaria"), the institutional shareholders and certain management team members and other shareholders of Silmäasema (the "Main Sellers"). The purchase price, cash- and debt-free, is

Inside information: Terveystalo updates its strategic focus, financial targets for the medium term and dividend policy

Terveystalo Plc, INSIDE INFORMATION, 8 June 2026 at 08:00 (EEST) Inside information: Terveystalo updates its strategic focus, financial targets for the medium term and dividend policy Terveystalo Plc’s ("Terveystalo") Board of Directors has approved the company’s updated strategic focus, financial targets, and profit distribution policy for the medium term. The updated targets reflect the company's renewed focus on growth in selected healthcare verticals and on scaling its leading digital solutions across healthcare retail to drive value creation. Renewed strategic focus on growth

Terveystalo Group Interim Report January–March 2026: Despite the difficult demand environment, profitability remained at a good level

Terveystalo Plc, Interim Report 24 April 2026 at 09:00 EEST This release is a summary of Terveystalo's Interim Report January–March 2026. The full release is attached to this stock exchange release and is available on our website at: https://www.terveystalo.com/en/company/investors/reports-and-presentations/ January–March 2026 in brief · Revenue decreased by 11.2 percent year-on-year to EUR 308.2 (346.9) million. · In Healthcare Services, revenue decreased by 9.6 percent and was EUR 253.6 (280.6) million. · In Portfolio Businesses, revenue decreased by 22.4 percent and

Terveystalo Q1/2026 result webcast and conference call on 24 April 2026

Terveystalo Press Release 10 April 2026 Terveystalo Plc will publish its Q1/2026 interim report on Friday 24 April 2026 at 9:00 EEST. Materials will be available soon after publication on Terveystalo’s IR website. Terveystalo will arrange a result webcast and conference call in English on 24 April 2026, starting at 10:30 EEST. You can watch the webcast online at: https://terveystalo.events.inderes.com/q1-2026 Conference call: https://events.inderes.com/terveystalo/q1-2026/dial-inYou can access the teleconference by registering through the link above. After the registration you

Changes in Terveystalo's Executive Team

Terveystalo Plc stock exchange release 31 March 2026 at 9:00 a.m. EET Two Senior Vice Presidents of the Healthcare Services business area have been appointed to Terveystalo's Executive Team, effective 1 April 2026. This business area is a key part of Terveystalo's strategy and generates almost 80% of the Group's total revenue. The Healthcare Services business area is headed by President and CEO Ville Iho. · Niki Kotilainen, Senior Vice President of Operations, Healthcare Services, b. 1985, M.Sc. (Tech.). Kotilainen has held several leadership roles at Terveystalo since 2015. Prior

Resolutions of the organising meeting of Terveystalo's Board of Directors

Terveystalo Plc, Stock Exchange Release 24 March 2026 at 14:00 EET Convening after the Annual General Meeting today, Terveystalo's Board of Directors elected Kari Kauniskangas as Chairman of the Board and Ari Lehtoranta as Vice Chairman of the Board. In addition, the Board elected the members of the Remuneration Committee and the Audit Committee from among its members: Petri Castrén was elected Chairman of the Audit Committee and Sofia Hasselberg and Ari Lehtoranta were elected members. Kari Kauniskangas was elected Chairman of the Remuneration Committee and Teija Sarajärvi and

Terveystalo Plc: Resolutions of Annual General Meeting

Terveystalo Plc, Stock Exchange Release 24 March 2026 at 12:30 p.m. EET The Annual General Meeting of Terveystalo Plc was held today on 24 March 2026 in Helsinki, Finland. The Annual General Meeting adopted the financial statements for the financial year 2025 and discharged the members of the Board of Directors and the CEO from liability. The Annual General Meeting approved the remuneration report for governing bodies. Use of the profit shown on the balance sheet and distribution of dividend The Annual General Meeting decided, in accordance with the proposal of the Board of

Terveystalo Plc - Managers' transactions - Iho

Terveystalo Plc, Managers' transactions, 11 March 2026 at 12:00 EET This is a notification under the Market Abuse Regulation (MAR) that President and CEO Ville Iho has received shares in Terveystalo as part of the performance share plan 2023-2025. Person subject to the notification requirement Name: Iho, Ville Position: Chief Executive Officer Issuer: Terveystalo Plc LEI: 7437001AEZHLL3UEX093 Notification type: INITIAL NOTIFICATION Reference number: 7437001AEZHLL3UEX093_20260311084840_79 ____________________________________________ Transaction date: 2026-03-10

Terveystalo Plc - Managers' transactions - Pajunen

Terveystalo Plc, Managers' transactions, 11 March 2026 at 12:00 EET This is a notification under the Market Abuse Regulation (MAR) that CFO Juuso Pajunen has received shares in Terveystalo as part of the performance share plan 2023-2025. Person subject to the notification requirement Name: Pajunen, Juuso Position: Chief Financial Officer Issuer: Terveystalo Plc LEI: 7437001AEZHLL3UEX093 Notification type: INITIAL NOTIFICATION Reference number: 7437001AEZHLL3UEX093_20260311084841_81 ____________________________________________ Transaction date: 2026-03-10

Terveystalo Plc - Managers' transactions - Mäenalanen

Terveystalo Plc, Managers' transactions, 11 March 2026 at 12:00 EET This is a notification under the Market Abuse Regulation (MAR) that EVP Henri Mäenalanen has received shares in Terveystalo as part of the performance share plan 2023-2025. Person subject to the notification requirement Name: Mäenalanen, Henri Position: Other senior manager Issuer: Terveystalo Plc LEI: 7437001AEZHLL3UEX093 Notification type: INITIAL NOTIFICATION Reference number: 7437001AEZHLL3UEX093_20260311084854_83 ____________________________________________ Transaction date: 2026-03-10

Terveystalo Plc - Managers' transactions - Saviharju

Terveystalo Plc, Managers' transactions, 11 March 2026 at 12:00 EET This is a notification under the Market Abuse Regulation (MAR) that General Counsel Elina Saviharju has received shares in Terveystalo as part of the performance share plan 2023-2025. Person subject to the notification requirement Name: Saviharju, Elina Position: Other senior manager Issuer: Terveystalo Plc LEI: 7437001AEZHLL3UEX093 Notification type: INITIAL NOTIFICATION Reference number: 7437001AEZHLL3UEX093_20260311084841_82 ____________________________________________ Transaction date: 2026-

Notice to the Annual General Meeting

Notice is given to the shareholders of Terveystalo Plc (the “Company”) to participate in the Annual General Meeting to be held on Tuesday, 24 March 2026 at 10:00 a.m. (EET) at Kulttuurikasarmi (in between Lasipalatsi and Kamppi Center) at the address Narinkka 2, 00100 Helsinki, Finland. The reception of participants and the distribution of voting tickets will commence at the meeting venue at 9:00 a.m. (EET). Shareholders and their proxy representatives may also exercise their voting rights by voting in advance. Instructions for advance voting are presented in this notice under section C “

Terveystalo's Annual Report 2025 published

Terveystalo Plc, Stock Exchange Release, 27 February 2026 at 09:00 am EET Terveystalo Plc’s Report of the Board of Directors and Financial Statements 2025 were published today. The Report of the Board of Directors includes the Sustainability statement, which has been prepared based on the Corporate Sustainability Reporting Directive (CSRD) and in accordance with the sustainability reporting standards (ESRS). Authorised Sustainability Audit Firm KPMG Oy Ab has verified the sustainability statement in accordance with the ISA 3000 assurance standard as a limited assurance engagement.

Hilppa Rautpalo appointed Terveystalo's SVP, Human Resources and member of the Group Management Team

Terveystalo Plc Stock Exchange Release 16 February 2026 at 15:00 a.m. EET Hilppa Rautpalo, Master of Laws (trained at the bench), born in 1974, has been appointed Senior Vice President of Human Resources and a member of the Group's Management Team. She will start in the position no later than 14 August 2026. Hilppa Rautpalo will report to President and CEO Ville Iho. Hilppa Rautpalo has extensive experience leading Human Resources and Legal Affairs at several companies across various industries. Rautpalo joins Terveystalo from Lassila & Tikanoja, where she serves as Senior Vice

Terveystalo Plc's Board of Directors has approved a new performance period covering years 2026‒2028 of the long-term share-based incentive plan for key personnel

Terveystalo Plc, Stock exchange release 13 February 2026 at 09:05 EET Terveystalo Plc's Board of Directors has approved a new performance period covering the years 2026–2028 of the long-term share-based incentive plan for key personnel. The purpose of the programme is to align the objectives of shareholders and key personnel to increase the company's value in the long term, and to commit key personnel to implementing Terveystalo's strategy by offering them a competitive, share-based incentive programme. The Performance Share Plan is based on a rolling 3-year performance period

Proposals of Terveystalo’s Board of Directors to the Annual General Meeting 2026

Terveystalo Plc Stock Exchange Release 13 February 2026 at 9:02 EET Terveystalo Plc’s Board of Directors has decided to propose to the Annual General Meeting to be held on 24 March 2026 that a total dividend of EUR 0.64 per share be paid for 2025. The Board of Directors proposes that the dividend is paid in two instalments. The Board further proposes the adoption of the Financial Statements, approval of the Remuneration Report for governing bodies, amendment of the Articles of Association, authorizing the Board to decide on the repurchase and/or on the acceptance as pledge of the Company’

Terveystalo Group Financial Statements Release 2025: Strong profitability in an increasingly challenging market environment

Terveystalo Plc, Financial Statements Release, 13 February 2026 at 09:00 EET This release is a summary of Terveystalo's Financial Statements Release 2025. The full release is attached to this stock exchange release and is available on Terveystalo’s website at: https://www.terveystalo.com/en/company/investors/reports-and-presentations/. October–December 2025 in brief · Revenue decreased by 6.8 percent year-on-year to EUR 330.0 (353.9) million.The reporting period had one more working day than the comparison period.The Healthcare Services segment revenue decreased by 5.3

Terveystalo Q4/2025 result webcast and conference call on 13 February 2026 at 10:30 EET

Terveystalo Press Release 28 January 2026 Terveystalo Plc will publish its Financial Statements Release 2025 on Friday 13 February 2026 at 9:00 EET. Materials will be available soon after publication on Terveystalo’s IR website. Terveystalo will arrange a webcast and conference call in English on the same day, starting at 10:30 EET.You can watch the webcast online at: https://terveystalo.events.inderes.com/q4-2025 You can access the teleconference by registering at the link below.https://events.inderes.com/terveystalo/q4-2025/dial-inAfter the registration, you will be

Terveystalo acquires Silmäsairaala Pilke Oy and Turun Silmälaser Oy – strengthens position in eye surgery

Terveystalo Plc, press release, 7 January 2026 Terveystalo Healthcare Plc signed agreements on 3 December 2025 to acquire all shares in Silmäsairaala Pilke Oy and Turun Silmälaser Oy (collectively “Silmäsairaala Pilke”). The transactions were completed on 31 December 2025. Silmäsairaala Pilke provides ophthalmology services, eye examinations, and advanced surgical procedures, including cataract, lens, and refractive surgeries, primarily for private customers. In 2024, the companies' combined revenue was approximately EUR 8.2 million. Silmäsairaala Pilke employs around 35 professionals

Inside information: Terveystalo acquires Hohde Group

Terveystalo Plc INSIDE INFORMATION 23 December 2025 at 8:00 a.m. EETTerveystalo Healthcare Oy ("Terveystalo") today, 23 December 2025, signed an agreement to acquire Hohde Group, consisting of Hammas Hohde Oy dental clinics and Loisto Laboratoriot Oy dental laboratories (the "Arrangement"). If completed, the arrangement would strengthen the Terveystalo Group's oral health services for different customer groups. The arrangement is expected to be completed in 2026, subject to the approval of the Finnish Competition and Consumer Authority. The Enterprise value (EV) of the target,

Terveystalo to sell Sauma Child Welfare Services Ltd to Validia Ltd

Terveystalo Plc, Press Release, 19 December 2025 at 11:00 EET Terveystalo Plc has signed an agreement to sell Sauma Child Welfare Services Ltd to Validia Ltd. Completion of the transaction is subject to approval by the Finnish Competition and Consumer Authority. Sauma provides specialised and demanding child welfare residential care and foster care services. In 2024, the company’s revenue was 11.4 million euros, and it employed approximately 230 people. The transaction is based on Terveystalo’s strategic decision to sharpen its focus and strengthen its position as the most trusted

Proposals of the Shareholders' Nomination Board of Terveystalo for the Annual General Meeting 2026

Terveystalo Plc Stock Exchange Release 19 December 2025 at 09:05 EET The Shareholders' Nomination Board of Terveystalo has submitted to the Board of Directors its proposals for the Annual General Meeting 2026. Proposal on the number of members of the Board of Directors and its composition The Shareholders' Nomination Board proposes to the Annual General Meeting that the number of members of the Board of Directors shall be six (6). The Nomination Board proposes, for a term that ends at the end of the Annual General Meeting 2027, that Kari Kauniskangas, Sofia Hasselberg, Ari

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe

Media